News | April 15, 2014

Mevion Announces Partnership With Chiyoda Technol for Distribution of Proton Therapy Systems in Japan

April 15, 2014 — Mevion Medical Systems announced an agreement with Chiyoda Technol Corp. for the exclusive distribution of the Mevion S250 proton therapy system in the Japanese market. Chiyoda Technol is one of Japan’s leading providers of radiation supply, service and monitoring.

The Mevion S250 system is a single-room, gantry-mounted proton accelerator that frees hospitals and private treatment facilities from the high costs, prohibitive space requirements and cumbersome workflow that commonly define the treatment modality.

“The significantly reduced size and cost of the Mevion S250, paired with cutting-edge technology, is a perfect fit for the very progressive Japanese radiation therapy market,” said Kazuhiko Yamaguchi, president of Chiyoda Technol Corp. “We have a strong tradition of introducing state-of-the-art medical products and with the addition of the Mevion S250 proton therapy system, we are fulfilling the demand of our foremost customers and we expect to significantly increase the number of proton therapy centers in the next five years.”

“Mevion is proud to expand its partnership with Chiyoda Technol to provide this revolutionary proton therapy platform to clinicians and patients in Japan”, said Joseph K. Jachinowski, CEO of Mevion. “With Japan’s 20-year leadership in the clinical use of proton therapy, the Japanese market has always been a high priority and we are excited to see the very positive response the Mevion S250 is receiving from all proton experts.”

The Mevion S250 is installed at the Kling Proton Therapy Center at Barnes-Jewish Hospital at Washington University in St. Louis, benefiting pediatric patients and other cancer patients where proton therapy treatment is indicated. Five additional systems are under installation at Robert Wood Johnson University Hospital in New Brunswick, N.J.; Stephenson Cancer Center at the University of Oklahoma in Oklahoma City; First Coast Oncology in Jacksonville, Fla.; University of Florida Health Cancer Center at Orlando Health; and University Hospitals Seidman Cancer Center in Cleveland.

For more information:

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init